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Background: Accurate identification of eosinophils in the gastrointestinal (GI) tract of dogs with
eosinophilic GI disease (EGID) by histological evaluation is challenging. The currently used
hematoxylin and eosin (H&E) staining method detects intact eosinophils but does not detect
degranulated eosinophils, thus potentially underrepresenting the number of infiltrating
eosinophils.
Objective: To develop a more sensitive method for identifying and quantifying both intact and
degranulated eosinophils to diagnose EGID more accurately.
Methods: Endoscopically obtained paraffin-embedded intestinal biopsy specimens from dogs
with GI signs were examined. The study groups were dogs with eosinophilic enteritis (EE), lym-
phoplasmacytic and mixed enteritis, and control dogs with GI signs but no histologic changes on
tissue sections. Consecutive sections were immunolabeled with monoclonal antibodies (mAbs)
against the eosinophil granule protein eosinophil peroxidase (Epx) and stained by H&E, respec-
tively. The number of eosinophils was manually quantified and classified as intact or
degranulated.
Results: The number of intact eosinophils detected in Epx mAb-labeled duodenal sections was
significantly higher compared with that in H&E-stained sections, with a similar relationship
noted in the colon and stomach. The Epx mAb allowed the unique assessment of eosinophil
degranulation. The number of intact and degranulated eosinophils was significantly higher in
duodenal lamina propria of the EE and mixed group compared to the control group.
Conclusion: Immunohistochemical detection of Epx provides a more precise method to detect
GI tract eosinophils compared to H&E staining and could be used as an alternative and reliable
diagnostic tool for assessment of biopsy tissues from dogs with EGID.
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1 | INTRODUCTION
Eosinophilic gastrointestinal disease (EGID) includes a spectrum of dis-
orders defined by eosinophilic inflammation in ≥1 sites (ie, esophagus,
stomach, intestine, and colon) of the GI mucosa without any known
cause for such infiltration (eg, drug reactions, parasitic infections,
malignancy, and other causes).1,2 Eosinophils play a crucial role in
innate and adaptive immunity of the GI tract by participating in host
defense against luminal pathogens and maintaining intestinal epithelial
homeostasis.3–5 In dogs, IBD is the term used to describe persistent
or recurrent GI signs (eg, weight loss, vomiting, and diarrhea) and his-
topathological evidence of intestinal inflammation without underlying
Abbreviations: EE, eosinophilic enteritis; EGID, eosinophilic gastrointestinal dis-
ease; Epx, eosinophil peroxidase; GI, gastrointestinal; H&E, hematoxylin and
eosin; IBD, inflammatory bowel disease; IHC, immunohistochemistry; LP, lamina
propria; LPE, lymphoplasmacytic enteritis; mAb, monoclonal antibody
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causes (eg, infection, endocrine, and neoplastic disease).6,7 Mucosal
inflammation is a characteristic histopathological feature of IBD and
the primary forms of small intestinal IBD in dogs are LPE, character-
ized by increased numbers of lymphocytes and plasma cells, and EE,
which is characterized by infiltration predominantly of eosinophils.6
Eosinophils are multifunctional granulocytes that, upon activation,
play a critical role in regulating innate and adaptive immune responses
by release of various mediators such as cytokines, growth factors,
chemokines, and cytotoxic granule proteins (degranulation).4,8 Pre-
formed cytotoxic granule proteins such as eosinophil cationic protein,
Epx, and major basic protein released by activated eosinophils during
inflammation can contribute to tissue damage and dysfunction.9–12
Therefore, it is important to accurately detect not only intact eosino-
phils with intracellular granule proteins but also extracellular release
of granule proteins by activated eosinophils, to obtain a better under-
standing of the contribution of eosinophil activation to disease patho-
genesis. The pathophysiological effects associated with eosinophilic
infiltration of the GI tract remain poorly defined.4 Histological evalua-
tion of endoscopic biopsy specimens is performed frequently in the
diagnosis and management of dogs with IBD. This evaluation entails
detailed characterization of the inflammatory infiltrate (ie, lympho-
cytes, plasma cells, and eosinophils), the area affected (ie, focal or gen-
eralized, superficial, or deep), the severity of inflammation (ie, mild,
moderate, and severe), and any microarchitectural changes (ie, villus
fusion or atrophy and fibrosis).13
The assessment of GI mucosal inflammation, including the quanti-
fication of eosinophils, by H&E staining of biopsy tissues in conjunc-
tion with exclusion of underlying disease is used as a guideline in the
diagnosis of IBD.14 However, H&E staining can only detect intact but
not degranulated, eosinophils, and therefore may underrepresent the
extent of eosinophilic infiltration.15 Although eosinophils are present
in the normal small intestinal mucosa, the distinction between the
upper limit of normal and abnormally increased tissue eosinophils is
not clearly defined using H&E staining.14,16,17 Using jejunal tissue col-
lected at necropsy examination from dogs with IBD, we previously
have demonstrated that IHC using a mAb specific for the eosinophil
granule protein Epx allows reliable morphological identification of
degranulated as well as intact eosinophils and could serve as a tool for
quantitative evaluation of eosinophils in the small intestine.15 Our
specific aim in the present study was to quantify and compare eosino-
phil counts by H&E versus Epx mAb IHC of endoscopically obtained
biopsy specimens from a larger, clinically well-defined cohort of dogs
to further our understanding of the role of eosinophils and eosinophil
degranulation in intestinal inflammation in dogs.
2 | MATERIALS AND METHODS
2.1 | Animals and samples
Thirty dogs (17 male and 13 female) were included in our retrospec-
tive study based on duodenal histopathology of endoscopic biopsy
specimens from cases submitted to the Pathology Unit of University
of Bristol, Bristol, United Kingdom. Dogs were of 17 different breeds:
Terrier-cross (n = 2), German Shepherd (n = 3), Labrador Retriever
(n = 6), Dachshund (n = 2), Jack Russell Terrier (n = 3), Cross-bred
(n = 2), Cavalier King Charles Spaniel (n = 2), and 1 each of the follow-
ing breeds: Miniature Schnauzer, Pit Bull Terrier, Saluki, Doberman
Pincher, Boxer, Staffordshire Bull Terrier, Lurcher, Chihuahua,
Rhodesian Ridgeback, and Foxhound. The study population included
dogs with EE (n = 10; median age, 5.5 years, with a mean  standard
deviation [STD] of 5.5  3.8 years) and dogs with mixed eosinophilic/
LPE (n = 10; median age, 3.5 years, with a mean  STD of
4.5  3.1 years). Because endoscopic biopsy of healthy dogs is not
permitted at the Pathology Unit of University of Bristol, the control
group (n = 10; median age, 3.5 years, with a mean  STD of
4.5  2.8 years) comprised dogs with a variety of GI signs (eg, regurgi-
tation, vomiting, weight loss, intermittent diarrhea, and abdominal
pain) requiring endoscopic investigation, but in which intestinal biopsy
specimens were assessed as histologically normal. All dogs underwent
standard investigations consisting of hematological examination,
serum biochemistry, serum folate and cobalamin concentrations, basal
cortisol concentration or ACTH stimulation test, urinalysis, and
abdominal imaging (transabdominal ultrasound examination, radio-
graphs, or computed tomography). Fecal parasitological examinations
were performed in all dogs unless they had recently undergone trial
treatment with fenbendazole before referral, and all were negative.
Records before referral were sometimes incomplete, but no dog was
reported to have responded to a diet trial, and all dogs had been on a
regular diet without administration of any immunosuppressive agents
or antibiotics for at least 2 weeks before endoscopy. Final diagnoses
included pancreatitis, megaesophagus protein-losing nephropathy,
food-responsive enteropathy, hiatal hernia, or unknown.
Available tissue consisted of adequate endoscopically obtained
biopsy specimens of the stomach (fundus, n = 30; antrum, n = 24),
duodenum (n = 30), and colon (n = 10) that were formalin fixed and
paraffin embedded. The original histopathology report for each dog
provided information on 4 morphologic variables (ie, epithelial injury,
crypt distension, lacteal dilatation, and mucosal fibrosis) and 4
inflammatory variables (intraepithelial lymphocytes, LP lymphocytes
and plasma cells, LP eosinophils, and LP neutrophils) in accordance
with the World Small Animal Veterinary Association guidelines.13 Each
variable was scored by a veterinary pathologist (MJD) as: 0 = normal,
1 = mild, 2 = moderate, or 3 = marked, as previously described.13
Because architectural changes were limited, histopathological severity
was quantified by the numerical score attributed to the inflammatory
infiltration. In addition, the dominant inflammatory population was
recorded and biopsy specimens were classified as containing only
eosinophilic or lymphoplasmacytic and eosinophilic (referred to as
mixed enteritis) inflammation. Based on this scoring system, 8 dogs
were scored as having mild EE or mixed enteritis and 12 dogs were
scored as having moderate EE or mixed enteritis.
2.2 | Histology and immunohistochemistry
Serial 4-μm-thick sections were cut from each paraffin block.
Section 1 was stained with H&E, whereas Sections 2 and 3 were
immunolabeled with Epx mAb (Mayo Clinic, Scottsdale, Arizona) and
normal mouse IgG (negative control, Sigma-Aldrich, St. Louis,
Missouri), respectively, as previously described.15 Slides were
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evaluated using an Olympus BX53 upright light microscope and pho-
tomicrographs were acquired using an Olympus DP73 camera and
Olympus cellSens Software (Olympus, Center Valley, Pennsylvania).
2.3 | Quantification of eosinophils
Eosinophils were quantified in each H&E-stained and Epx mAb-labeled
tissue section in a blinded fashion (IB). Several randomly selected
sections were evaluated separately by an American College of Veterinary
Pathologists Diplomate (DS) to ensure consistency in quantitation. For
each case, the 5 largest biopsy tissue sections on the slide were evalu-
ated for each organ. For each tissue section, eosinophils were manually
quantified in contiguous ×400 fields spanning the entire section (range,
10-25 fields, depending on the size of the section). Eosinophils were
classified as either intact or degranulated. Degranulated eosinophils were
identified based on immunopositive Epx staining in the extracellular
space (ie, free cytoplasmic granules, extracellular matrix deposition of
eosinophil secondary granule proteins, or both), which corresponded to
an adjacent nucleus that fitted the morphologic criteria for an eosinophil
(ie, hyperchromatic bilobed nucleus) as described previously.15,18 In the
case of duodenum, the microscopic location of each cell was defined as
either upper (villus) or lower LP (between the muscularis mucosae and
crypts) and for the stomach the location was defined as either antrum or
fundus. Degranulated eosinophils were quantitated only in duodenal
biopsy specimens (not stomach and colon). The average number of
eosinophils per field first was calculated for each region (ie, stomach
[antrum and fundus], duodenum [upper and lower LP], and colon) and
type (H&E [intact], Epx [intact], and Epx [degranulated]) combination for
each dog and used for all further analyses.
2.4 | Statistical analysis
Samples from dogs diagnosed as having marked inflammation based on
histopathological scoring were combined with those with moderate
cellular infiltration as a single group in the statistical analysis. Visual
inspection indicated that the data were not normally distributed, with
substantial skew and several outlying points. To compare the 2 mea-
surement types for intact eosinophils, H&E (intact) and Epx (intact),
paired Wilcoxon tests were performed for each region separately. To
compare the disease groups (control, EE, and mixed) and severity levels
(control, mild, and moderate) for each duodenum region (upper LP and
lower LP) and type (Epx only) combination, pairwise Wilcoxon tests
were performed, with P values corrected for multiple comparisons
within each region and type using the Bonferroni-Holm correction. Sta-
tistical analysis was performed using R Statistical Software (version
3.4.3). All tests were considered significant at a value of P ≤ .05.
3 | RESULTS
3.1 | Evaluation of eosinophil infiltration by H&E
staining versus Epx mAb immunolabeling
H&E-stained sections of the duodenum from dogs with intestinal
inflammation (EE or mixed enteritis) disclosed the presence of a mixed
cellular infiltrate consisting primarily of eosinophils or a mixture of
eosinophils, lymphocytes, and plasma cells. Duodenal sections of con-
trol dogs did not show any abnormal cellular infiltrates. The density of
eosinophil infiltration in duodenal sections of these groups of dogs
after H&E staining was quantified by manual counting and then com-
pared with eosinophil numbers quantified after IHC with Epx mAb.
The number of eosinophils detected per ×400 microscopic field after
Epx mAb IHC in both the upper and lower LP was significantly higher
than that detected in H&E-stained sections in each of the groups in
both regions (Figure 1). This finding was consistent in other regions of
the GI tract (ie, colon and stomach [fundus and antrum]). Quantitative
assessment of intact eosinophils detected by H&E staining and Epx
mAb IHC for each region of the GI tract for individual dogs is shown
in Figure 2. In all cases, the number of intact eosinophils detected
after Epx mAb IHC was higher than that detected by H&E staining,
thus demonstrating that routine H&E staining alone underrepresents
the number of eosinophils present.
Although H&E staining detected only intact eosinophils in duode-
nal sections from dogs with eosinophilic or mixed inflammation, Epx
IHC easily allowed identification of intact eosinophils based on the
prominent dark red-brown color within intracellular membrane-bound
secondary granules and as well as degranulated eosinophils with dif-
fuse extracellular granule staining (Figure 3). This finding is consistent
with our previous study using jejunal tissue collected at the time of
necropsy examination from dogs with IBD in which Epx IHC detected
both intact and degranulated eosinophils.15 Representative H&E-
stained and Epx-labeled images showing the presence and distribution
of eosinophils in the lower and upper LP of the duodenum of control
dogs and dogs with EE or mixed enteritis are shown in Figure 4.
3.2 | Quantitative assessment of intact and
degranulated eosinophils after Epx mAb labeling
Next, the number of intact and degranulated eosinophils in the upper
and lower regions of the duodenal LP in dogs with EE and mixed
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FIGURE 1 Quantitation of eosinophils in duodenal biopsy specimens
by hematoxylin and eosin (H&E) staining and eosinophil peroxidase
(Epx) immunolabeling. Average number of positively stained or labeled
intact eosinophils per high-power field at ×400 magnification in the
upper and lower LP in serial duodenal sections from control dogs
and dogs with either eosinophilic enteritis or mixed enteritis stained
with H&E and Epx monoclonal antibody immunohistochemical,
respectively
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enteritis and control dogs was quantified based on Epx IHC. A signifi-
cantly higher number of intact and degranulated eosinophils was
detected in the upper and lower LP of the samples from dogs with EE
and mixed enteritis compared with the number of intact and degranu-
lated eosinophils in these regions in control dogs. The number of
intact and degranulated eosinophils in the upper and lower regions of
the LP of dogs with EE and mixed enteritis was not significantly differ-
ent from each other (Figure 5).
In terms of disease severity (EE and mixed enteritis combined),
the number of intact eosinophils detected by Epx IHC was signifi-
cantly higher in the upper and lower LP in dogs with mild and moder-
ate disease compared with control dogs (Figure 6). Furthermore, the
number of intact eosinophils in the upper and lower LP of dogs with
moderate disease was significantly higher than in dogs with mild dis-
ease. In the case of degranulated eosinophils, compared with control
dogs, the number of these cells was significantly higher in the upper
and lower LP in dogs with moderate disease and only in the upper LP
for dogs with mild disease. No significant difference in the number of
degranulated eosinophils was noted between dogs with mild and
moderate disease in the upper or lower LP.
4 | DISCUSSION
Eosinophils are present in the healthy human and canine intestine in
variable number.14,16,17 Abnormal accumulation of eosinophils in the
intestine in the absence of other underlying causes (eg, parasitic infec-
tions) is a characteristic feature of EGID, including IBD.4,19 Staining of
duodenal biopsy specimens with H&E for histopathological evaluation
is routinely performed during diagnosis of IBD in dogs.13,14 In a previ-
ous study, we determined that unlike H&E staining, which detects
only intact eosinophils, Epx IHC allows reliable identification of intact
and degranulated eosinophils in jejunal tissue (collected at necropsy)
of dogs with IBD, and potentially could allow quantitative analysis of
eosinophils in the small intestine.15 In the current study, we have
extended these findings to endoscopically obtained biopsy specimens
from the stomach, duodenum, and colon of dogs with GI inflammation
(EE or mixed enteritis) and confirmed the utility of this technique in
eosinophil identification and quantitation using clinically relevant
samples.
Evaluation of serial sections of duodenal biopsy specimens from
control dogs and dogs with either EE or mixed enteritis that were
stained with H&E and labeled with Epx mAb indicated that Epx mAb-
based IHC consistently results in detection of significantly higher num-
bers of intact eosinophils relative to H&E staining. A similar finding was
observed on evaluation of serially stained sections (using H&E and Epx
mAb) from the stomach (antrum and fundus) and colon of these dogs.
These findings suggest that quantification of eosinophil infiltration
based on H&E staining is likely to be an underrepresentation of the
FIGURE 3 Eosinophil degranulation assessed by eosinophil peroxidase (Epx) immunohistochemistry (IHC). The presence of intact eosinophils
is noted in hematoxylin and eosin (H&E)-stained (left) and Epx-labeled (right) sections. Blue arrows in H&E-stained section indicate intact
eosinophils. The fine detail of eosinophil granules within the cytoplasm of intact eosinophils (black arrows) and in the extracellular matrix (red
arrows) indicating degranulation is noted only after Epx IHC. Scale bar = 20 μm
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FIGURE 2 Quantitative assessment of intact eosinophils detected by
hematoxylin and eosin (H&E) staining and eosinophil peroxidase (Epx)
immunolabeling for different regions of the gastrointestinal tract.
Average number of positively stained/labeled intact eosinophils per
high-power field at ×400 magnification in serial sections of colon,
duodenum (upper LP and lower LP), and stomach (antrum and fundus)
stained with H&E and Epx monoclonal antibody immunohistochemistry,
respectively. Data for individual dogs in the control, eosinophilic (mild
and moderate), and mixed (mild and moderate) enteritis groups are
shown
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magnitude of inflammation. Previous studies using esophageal tissue
sections from human patients with eosinophilic esophagitis have shown
that Epx mAb-based IHC detects a 4-fold higher number of eosinophils
compared with H&E staining and potentially enables differentiation of
difficult-to-diagnose eosinophilic esophagitis and gastroesophageal
reflux disease.20 In another study using lung biopsy specimens from
patients with acute lung injury, a >40-fold higher sensitivity in the
detection of eosinophils was achieved by IHC with Epx mAb relative to
H&E-stained sections, resulting in the identification of higher numbers
of eosinophils in these patients compared with controls in whom differ-
ences using H&E staining alone were not significant.18 Similar findings
were observed in canine skin in which Epx mAb IHC detected signifi-
cantly higher numbers of eosinophils as compared to H&E staining.21
Based on our findings of enhanced detection of intact eosinophils by
Epx mAb-based IHC relative to H&E staining, this method could be
used to accurately assess eosinophilic inflammation in formalin-fixed
and paraffin-embedded tissues from the duodenum, stomach and colon
to improve diagnostic sensitivity for EGID in dogs.
Eosinophilic gastrointestinal disease often is caused by food
allergen-driven Th2 inflammation that is likely to be responsible for
the predominant infiltration of eosinophils.22 When activated,
FIGURE 4 Eosinophils in duodenum of control, eosinophilic enteritis,
and mixed enteritis groups of dogs by hematoxylin and eosin (H&E)
staining and eosinophil peroxidase (Epx) labeling. Distribution of
eosinophils within the upper and lower lamina propria (LP) of control,
eosinophilic, and mixed enteritis groups of dogs. H&E-stained sections
are on the left, and Epx IHC sections on the right. Note the ease in
observing eosinophils in Epx-labeled versus H&E-stained sections in
the upper and lower LP within each group. Scale bar = 20 μm
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FIGURE 6 Quantitation of intact and degranulated eosinophils in
duodenal biopsy specimens based on disease severity. Average
number of eosinophil peroxidase-positive intact and degranulated
cells per high-power field at ×400 magnification in the upper and
lower lamina propria from control (Con) dogs and dogs with mild or
moderate (Mod) disease (eosinophilic and mixed enteritis groups
combined in this analysis) is shown. Histopathological severity is
based on the cumulative numerical score determined according to
World Small Animal Veterinary Association guidelines
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FIGURE 5 Quantitation of intact and degranulated eosinophils in
duodenal biopsy specimens based on disease type. Average number
of positively labeled intact and degranulated cells per high-power field
at ×400 magnification in the upper and lower lamina propria of
control (Con) dogs and dogs with eosinophilic enteritis (Eos) or mixed
enteritis (Mix) after eosinophil peroxidase monoclonal antibody
immunohistochemical
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eosinophils can secrete various preformed inflammatory cytokines
such as interleukin (IL)-4, IL-5, IL-10, IL-12, and IL-13 as well as
growth factors (eg, transforming growth factor [TGF]-β), chemokines
(regulated on activation, normal T cell expressed and secreted and
eotaxin-1), lipid mediators (platelet-activating factor and leukotriene
C4), and cytotoxic granule proteins.23 These inflammatory mediators
are known to induce various effects such as up-regulation of adhesion
molecules to modulate cellular trafficking and recruitment, mucus
secretion, tissue remodeling, and impairment of barrier integrity,24,25
which can contribute to disease progression. For example, eosinophil-
derived TGF-β is linked to tissue remodeling and induction of the
extracellular matrix protein periostin in patient biopsy specimens
which increases eosinophil infiltration in the mucosal layer, thus facili-
tating disease pathogenesis.26,27 Furthermore, as indicated above,
granule proteins such as eosinophil cationic protein, Epx, and major
basic protein released by activated eosinophils during inflammation
can contribute to tissue damage (alter barrier function) and dysfunc-
tion (diarrhea with bleeding).9–12 Deficiency of eotaxin-1, the
eosinophil-specific chemokine, or blockade of its receptor (CCR3)
resulting in depletion of eosinophils has been shown to attenuate
inflammation in experimental models of IBD,9,28 thus supporting the
overall importance of eosinophil involvement in EGID.
One of the limitations of H&E staining is its inability or poor abil-
ity to detect degranulated eosinophils.15 Studies in patients with dif-
ferent forms of GI eosinophilic inflammation have shown increased
numbers of activated eosinophils and increased concentrations of
extracellular granule protein, suggesting that these cells may be
important players in promoting and mediating inflammation in the
intestinal mucosa.29–32 Therefore, it is important to be able to reliably
detect and quantify both intact and degranulated eosinophils in order
to better understand their involvement and contribution to disease
pathogenesis. In our previous study, enumeration of eosinophils after
Epx mAb IHC indicated the presence of increased numbers of degra-
nulated eosinophils in the upper and lower LP of the jejunum in dogs
diagnosed with IBD compared with control dogs and dogs that had
been treated for IBD.15 The current study confirms this observation in
the duodenum of dogs with EE or mixed enteritis. In both cases, the
number of degranulated eosinophils was significantly higher than in
control dogs. The presence of an increased number of degranulated
eosinophils in the upper and lower LP may be a previously unrecog-
nized feature of IBD. Previous studies indicate that eosinophil granule
proteins (eg, eosinophil cationic protein, major basic protein) released
by activated eosinophils contribute to tissue damage and inflamma-
tion during GI disorders and may be indicative of active ongoing
disease.3,10,30,33,34
Interestingly, in the current study, tissue from dogs with EE and
mixed enteritis had similar numbers of intact and degranulated eosino-
phils after Epx mAb IHC, suggesting that eosinophils are an important
cellular component of disease pathogenesis in both of these histologic
forms of IBD. Eosinophil peroxide mAb-based IHC clearly differenti-
ates between mild and moderate disease based on the number of
intact eosinophils in the lower and upper LP. Furthermore, a consis-
tently higher number of degranulated eosinophils was found in duode-
nal tissue from dogs with moderate disease compared to dogs with
mild disease, although it did not reach statistical significance. Although
one would expect degranulation to correlate with severity, it is still
unclear how many eosinophils must degranulate to increase disease
severity, and our study group may not have been large enough (ie,
small sample size) to establish a statistically significant difference. Fur-
thermore, discordance may exist between histological changes and
severity of disease, and a disease activity index was not calculated for
these dogs. Similarly, in our previous study a significant difference in
the number of intact eosinophils was noted between dogs with IBD
(untreated) and treated IBD dogs, albeit only in the upper LP.15 Based
on the observation that H&E staining resulted in an underrepresenta-
tion of the number of eosinophils (intact) relative to Epx mAb IHC not
only in the duodenum but also in the stomach and colon in the current
study, it is possible that evaluation of biopsy specimens by H&E stain
only may result in underdiagnosis of disease as well as severity of dis-
ease in dogs with EGID.
A limitation of our study is that the control group consisted of
dogs with various GI signs but with histologically normal intestinal
biopsy specimens and were not healthy controls. Additionally, infor-
mation regarding the diets that the dogs were fed was limited and
therefore could not be controlled in the study. Evaluating the correla-
tion of Epx mAb IHC to treatment outcome (ie, diet), can be the basis
of a future investigation. Overall, we have demonstrated that detec-
tion of eosinophils by IHC with Epx mAb provides a more accurate
and reliable method for detection of tissue-infiltrating eosinophils in
duodenal biopsy specimens for the diagnosis of EGIDs such as IBD in
dogs. This technique can be used as an alternative or additional diag-
nostic tool in assessment of dogs with IBD. Importantly, Epx mAb-
based IHC allows for the assessment of eosinophil degranulation and
thus enables a better understanding of the role of eosinophils and
their granule proteins in the pathogenesis of IBD in dogs.
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